Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “REVIVA PHARMACEUTICALS, INC.”

28 pharma patents match "REVIVA PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 28
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 28 pharmaceutical patents matching "REVIVA PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

28 results for “REVIVA PHARMACEUTICALS, INC.” · 30,257 patents in full index Clear search

  1. US 12053477

    Methods for treating pulmonary fibrosis

    REVIVA PHARMACEUTICALS, INC. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted

  2. US 10441590

    Methods for treating pulmonary hypertension

    REVIVA PHARMACEUTICALS, INC. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  3. US 10035761

    Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  4. US 9975862

    Arylpiperazine derivatives and methods of utilizing same

    REVIVA PHARMACEUTICALS, INC. · Granted May 22, 2018 · Expires May 17, 2038

    granted

  5. US 9907803

    Methods for treating attention deficit hyperactivity disorder

    REVIVA PHARMACEUTICALS, INC. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted

  6. US 9695116

    Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted

  7. US 9604944

    Arylpiperazine derivatives and methods of utilizing same

    REVIVA PHARMACEUTICALS, INC. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  8. US 9302981

    Synthesis, methods of using, and compositions of cycloalkylmethylamines

    REVIVA PHARMACEUTICALS, INC. · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  9. US 9296681

    Cycloalkylmethylamines

    REVIVA PHARMACEUTICALS, INC. · Granted Mar 29, 2016 · Expires Mar 24, 2036

    granted

  10. US 9255076

    Arylpiperazine derivatives and methods of utilizing same

    REVIVA PHARMACEUTICALS, INC. · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted

  11. US 9238625

    Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  12. US 9096515

    Methods of using cycloalkylmethylamine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  13. US 8980883

    Arylpiperazine derivatives and methods of utilizing same

    REVIVA PHARMACEUTICALS, INC. · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted

  14. US 8859552

    Methods of utilizing arylpiperazine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  15. US 8669285

    Synthesis, methods of using, and compositions of cycloalkylmethylamines

    REVIVA PHARMACEUTICALS, INC. · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted

  16. US 8604244

    Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  17. US 8580822

    Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors

    REVIVA PHARMACEUTICALS, INC. · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted

  18. US 8575185

    Compositions, synthesis, and methods of utilizing quinazolinedione derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  19. US 8461154

    Methods of utilizing arylpiperazine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  20. US 8445714

    Cycloalkylmethylamines

    REVIVA PHARMACEUTICALS, INC. · Granted May 21, 2013 · Expires May 16, 2033

    granted

  21. US 8431570

    Methods of utilizing arylpiperazine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  22. US 8372883

    Methods of using cycloalkylmethylamines

    REVIVA PHARMACEUTICALS, INC. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted

  23. US 8338632

    Cycloalkylmethylamines

    REVIVA PHARMACEUTICALS, INC. · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  24. US 8247563

    Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors

    REVIVA PHARMACEUTICALS, INC. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.